Resveratrol oligomers from Vatica albiramis.

Area of Science:

• Natural Product Chemistry
• Dermatology
• Biochemistry

Background:

• Vatica albiramis is a plant source of bioactive stilbenoids.
• Matrix metalloproteinase-1 (MMP-1) plays a role in skin aging and connective tissue degradation.
• Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that can induce MMP-1 production.

Purpose of the Study:

• To isolate and characterize new stilbenoids from Vatica albiramis.
• To evaluate the inhibitory effects of these new compounds on IL-1β-induced MMP-1 production in human dermal fibroblasts.

Main Methods:

• Isolation and structure elucidation of compounds using chromatographic and spectroscopic techniques.
• In vitro assays using human dermal fibroblasts to measure MMP-1 production after IL-1β stimulation.
• Quantification of MMP-1 levels using established biochemical assays.

Main Results:

• Five new stilbenoids, vatalbinosides A-E (1-5), were isolated, along with 13 known compounds (6-18).
• Three known resveratrol tetramers, (-)-hopeaphenol (6), vaticanol C (13), and stenophyllol C (14), demonstrated potent inhibition of MMP-1 production.
• The new compounds (1-5) were tested, but their inhibitory effects were not specified as strong.

Conclusions:

• Vatica albiramis is a rich source of stilbenoids with potential anti-aging properties.
• Specific resveratrol tetramers isolated from this plant are effective inhibitors of MMP-1 production.
• These findings suggest potential therapeutic applications for these compounds in managing skin conditions related to MMP-1 activity.